Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) insider Paul Herendeen bought 15,000 shares of Valeant Pharmaceuticals Intl stock in a transaction on Tuesday, March 13th. The stock was purchased at an average price of C$16.10 per share, for a total transaction of C$241,500.00.
Valeant Pharmaceuticals Intl Inc (TSE VRX) traded up C$1.12 during trading hours on Wednesday, reaching C$21.98. 1,850,282 shares of the company’s stock were exchanged, compared to its average volume of 1,809,298. The stock has a market cap of $7,260.00, a price-to-earnings ratio of 4.21 and a beta of -0.76. Valeant Pharmaceuticals Intl Inc has a 52 week low of C$11.20 and a 52 week high of C$30.56.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://ledgergazette.com/2018/03/14/valeant-pharmaceuticals-intl-inc-vrx-insider-purchases-c241500-00-in-stock.html.
Valeant Pharmaceuticals Intl Company Profile
Valeant Pharmaceuticals International, Inc is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices).
Receive News & Ratings for Valeant Pharmaceuticals Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl and related companies with MarketBeat.com's FREE daily email newsletter.